Morning Market Losers By: Benzinga via Benzinga October 02, 2015 at 09:51 AM EDT Amicus Therapeutics, Inc. (NASDAQ: FOLD) shares tumbled 55.13 percent to $6.17 following U.S. regulatory update for migalastat ... Read More >> Related Stocks: Amicus Therapeutics Coherus Bio Diplomat Pharmacy Inc Gilead Sciences Progress Software Realty Income Corp